Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: Implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species

被引:224
作者
Ito, K
Nakazato, T
Yamato, K
Miyakawa, Y
Yamada, T
Hozumi, N
Segawa, K
Ikeda, Y
Kizaki, M
机构
[1] Keio Univ, Sch Med, Dept Internal Med, Div Hematol,Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan
[3] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan
[4] Tokyo Med & Dent Univ, Grad Sch, Tokyo, Japan
[5] Sci Univ Tokyo, Inst Biol Sci, Chiba, Japan
关键词
D O I
10.1158/0008-5472.CAN-03-1670
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Capsaicin (N-vanillyl-8-methyl-1-nonenamide) is a homovanillic acid derivative found in pungent fruits. Several investigators have reported the ability of capsaicin to inhibit events associated with the promotion of cancer. However, the effects of capsaicin on human leukemic cells have never been investigated. We investigated the effects of capsaicin on leukemic cells in vitro and in vivo and further examined the molecular mechanisms of capsaicin-induced apoptosis in myeloid leukemic cells. Capsaicin suppressed the growth of leukemic cells, but not normal bone marrow mononuclear cells, via induction of G(0)-G(1) phase cell cycle arrest and apoptosis. Capsaicin-induced apoptosis was in association with the elevation of intracellular reactive oxygen species production. Interestingly, capsaicin-sensitive leukemic cells were possessed of wild-type p53, resulting in the phosphorylation of p53 at the Ser-15 residue by the treatment of capsaicin. Abrogation of p53 expression by the antisense oligonucleotides significantly attenuated capsaicin-induced cell cycle arrest and apoptosis. Pretreatment with the antioxidant N-acetyl-L-cystein and catalase, but not superoxide dismutase, completely inhibited capsaicin-induced apoptosis by inhibiting phosphorylation of Ser-15 residue of p53. Moreover, capsaicin effectively inhibited tumor growth and induced apoptosis in vivo using NOD/SCID mice with no toxic effects. We conclude that capsaicin has potential as a novel therapeutic agent for the treatment of leukemia.
引用
收藏
页码:1071 / 1078
页数:8
相关论文
共 57 条
  • [1] AGRAWAL RC, 1987, INDIAN J MED RES, V86, P391
  • [2] Regulation of p53 stability
    Ashcroft, M
    Vousden, KH
    [J]. ONCOGENE, 1999, 18 (53) : 7637 - 7643
  • [3] ASOU H, 1991, BLOOD, V77, P2031
  • [4] Enhanced phosphorylation of p53 by ATN in response to DNA damage
    Banin, S
    Moyal, L
    Shieh, SY
    Taya, Y
    Anderson, CW
    Chessa, L
    Smorodinsky, NI
    Prives, C
    Reiss, Y
    Shiloh, Y
    Ziv, Y
    [J]. SCIENCE, 1998, 281 (5383) : 1674 - 1677
  • [5] Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
    Canman, CE
    Lim, DS
    Cimprich, KA
    Taya, Y
    Tamai, K
    Sakaguchi, K
    Appella, E
    Kastan, MB
    Siliciano, JD
    [J]. SCIENCE, 1998, 281 (5383) : 1677 - 1679
  • [6] P53 IN CHRONIC MYELOGENOUS LEUKEMIA IN ACUTE PHASE
    FEINSTEIN, E
    CIMINO, G
    GALE, RP
    ALIMENA, G
    BERTHIER, R
    KISHI, K
    GOLDMAN, J
    ZACCARIA, A
    BERREBI, A
    CANAANI, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) : 6293 - 6297
  • [7] MUTATIONS OF THE P53-GENE IN ACUTE MYELOID-LEUKEMIA
    FENAUX, P
    PREUDHOMME, C
    QUIQUANDON, I
    JONVEAUX, P
    LAI, JL
    VANRUMBEKE, M
    LOUCHEUXLEFEBVRE, MH
    BAUTERS, F
    BERGER, R
    KERCKAERT, JP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (02) : 178 - 183
  • [8] FENAUX P, 1991, BLOOD, V78, P1652
  • [9] Detection of p53 gene mutations by single strand conformational polymorphism (SSCP) in human acute myeloid leukemia-derived cell lines
    Fleckenstein, DS
    Uphoff, CC
    Drexler, HG
    Quentmeier, H
    [J]. LEUKEMIA RESEARCH, 2002, 26 (02) : 207 - 214
  • [10] Establishment of a retinoic acid resistant human acute promyelocytic leukaemia (APL) model in human granulocyte-macrophage colony-stimulating factor (hGM CSF) transgenic severe combined immunodeficiency (SCID) mice
    Fukuchi, Y
    Kizaki, M
    Kinjo, K
    Awaya, N
    Muto, A
    Ito, M
    Kawai, Y
    Umezawa, A
    Hata, J
    Ueyama, Y
    Ikeda, Y
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (07) : 878 - 884